0
Should Medicare Be Covering Unproven Drugs? The Explosive Controversy that Exposes Big Flaws in Our Healthcare System.
On June 7, the F.D.A approved the use of the controversial Alzheimer’s treatment Aduhelm. This led to a backlash from many Alzheimer’s experts, who say that evidence for the drug’s effectiveness is limited.